long intergenic non-protein coding RNA 1708Genealiases: []
Q-omics provides the consensus-scored LINC01708 profile across patient tissues and cancer cell-line models. LINC01708 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, LINC01708 is differentially expressed in 4, with the highest sampling consensus in LUSC. Additionally, LINC01708 RNA expression shows 6,651 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KICH, LUSC, and STAD as cancer lineages where LINC01708 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01708 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01708 survival associations across molecular data types. LINC01708 RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01708 RNA expression–survival associations across cancer types. High LINC01708 expression shows unfavorable associations in KICH, LIHC, LGG, THCA, TGCT and KIRP. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for LINC01708 RNA expression.
This table summarizes LINC01708 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in LUSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01708. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01708 shows lower tumor expression in LUSC, LUAD and KICH and higher tumor expression in LIHC. The LUSC box plot shows higher LINC01708 RNA expression in normal versus tumor tissue (log2 FC = −0.331, t-test p < 0.001).
This table shows molecular features associated with LINC01708 in patient tissues and cancer cell lines. In patient samples, LINC01708 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
